PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 4 months ago Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases Financial Results Webcast Immunic Inc. Q2 2024 Inflammatory Diseases
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 4 months ago Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results Financial Framework Moderna Business Updates Q2 Revenues Vaccine Approvals
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 4 months ago Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals Conference Call Zomedica Corp. Veterinary Health Animals Q2 2024 Financial Results
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 4 months ago "NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides NanoViricides, Inc., reports on independent research highlighting NV-387's broad-spectrum action in viral therapy, potentially revolutionizing antiviral treatment strategies NV-387 NanoViricides Inc. Antiviral Nanomedicines Broad-spectrum Action Viral Therapy
PRESS RELEASE published on 08/01/2024 at 12:27, 1 year 4 months ago Nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2024 Electricite et Eaux de Madagascar publie sa declaration de capital et droits de vote conformement au Reglement General de l'Autorite des Marches Financiers Autorité Des Marchés Financiers Droits De Vote Règlement Général Electricité Et Eaux De Madagascar Declaration De Capital
PRESS RELEASE published on 08/01/2024 at 12:16, 1 year 4 months ago Total Voting Rights M&G Credit Income Investment Trust plc announces total voting rights as of 31 July 2024 per FCA rules M&G Credit Income Investment Trust Plc Total Voting Rights Transparency Rules Financial Conduct Authority Disclosure Guidance
PRESS RELEASE published on 08/01/2024 at 12:00, 1 year 4 months ago SUN.io Launches SUN DAO to Enhance Decentralized Governance and Drive Ecosystem Innovation SUN.io launches SUN DAO, a decentralized governance initiative on TRON blockchain, enhancing community autonomy and protocol governance. SUN DAO to revolutionize DeFi governance, incentivizing active participation and innovation Decentralized Governance DeFi SUN.io TRON Blockchain SUN DAO
PRESS RELEASE published on 08/01/2024 at 11:30, 1 year 4 months ago Iute Group reports unaudited 6M 2024 results on 22 August 2024 – Invitation to earnings webcast/call on the same day Iute Group invites investors to webcast/call on 22 August 2024 to discuss unaudited 6M 2024 results. CEO and CFO to present in English Investors Webcast Earnings Call Iute Group 6M 2024 Results
PRESS RELEASE published on 08/01/2024 at 11:30, 1 year 4 months ago Renewi plc: Holding(s) in Company Renewi plc reports major holdings notification by Avenue Europe International Management, L.P. on 29/07/2024. Details of voting rights and shareholders disclosed Shareholders Voting Rights Major Holdings Notification Renewi Plc Avenue Europe International Management
PRESS RELEASE published on 08/01/2024 at 11:20, 1 year 4 months ago MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory MindBio Therapeutics appoints Haywood Securities Inc. as strategic advisor to support investment initiatives. Company progressing with Phase 2B clinical trials for psychedelic medicine MB22001 Psychedelic Medicine Clinical Trials Investment MindBio Therapeutics Haywood Securities Inc.
Published on 12/24/2025 at 15:25, 4 hours 12 minutes ago CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Published on 12/24/2025 at 14:00, 5 hours 37 minutes ago Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
Published on 12/24/2025 at 14:00, 5 hours 37 minutes ago Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
Published on 12/24/2025 at 05:00, 14 hours 37 minutes ago Alphinat Inc. and the Hague Conference on Private International Law (HCCH) Today Announced the Launch of the New e-Country Profile Platform
Published on 12/24/2025 at 16:30, 3 hours 6 minutes ago ABB Ltd: ABB share buybacks - December 18, 2025 - December 23, 2025
Published on 12/24/2025 at 15:07, 4 hours 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/24/2025 at 15:06, 4 hours 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 12/24/2025 at 15:06, 4 hours 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/24/2025 at 15:05, 4 hours 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 12/22/2025 at 18:33, 2 days 1 hour ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 2 days 1 hour ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025